You are here: start » group_1_presentation_1_-_global_burden_of_disease_cardiovascular_disease

Differences

This shows you the differences between two versions of the page.

--- group_1_presentation_1_-_global_burden_of_disease_cardiovascular_disease [2017/01/27 13:41]
mateenm
+++ group_1_presentation_1_-_global_burden_of_disease_cardiovascular_disease [2018/01/25 15:19] (current)
@@ Line 1: / Line 1: @@
+====== The Global Burden of Disease ======
 ======History ======
@@ Line 131: / Line 131: @@
 ======Conclusion======
 The CDC is predicting 1.2 million Ebola cases by January 2015. However, the recent eradication of Ebola in Nigeria gives hope that, when proper preventative and control measures are taken, Ebola can be contained and the outbreak can be brought to an end. Worldwide efforts are needed in order to stop the spread of Ebola to other countries. Financial and healthcare support needs to continue to be sent to areas currently dealing with outbreaks. Initial control efforts in certain regions were hindered because there was disbelief that an Ebola outbreak was real and something to be concerned about. To ensure that citizens are willing to comply with and join control measures issued by governments and health agencies, we all need to be spreading awareness of the significance of Ebola but at the same time prevent unnecessary anxiety and false information from being passed on. Regardless of where you live, by everyone knowing how to recognize the signs of Ebola and what to do in case of an outbreak would greatly reduce the chance of an Ebola in other parts of the world. Humanity needs to join together and we all need to do what we can to help those who are effected and prevent others from being effected (Toner et al., 2014).
-======References======
-) Carter, A. (2014). Why Hamilton Shouldn’t Worry About Ebola. Retrieved from: http://www.cbc.ca/news/canada/hamilton/news/why-hamilton-shouldn-t-worry-about-ebola-1.2784273
-) CHCH News. (2014). Hamilton Health Sciences Would Handle Potential Ebola Patients. Retrieved from: http://www.chch.com/hamilton-health-sciences-handle-potential-ebola-patients/
-) Dixon, M. G., & Schafer, I. J. (2014). Ebola viral disease outbreak—West Africa, 2014. MMWR Morb Mortal Wkly Rep, 63(25), 548-51.
-) Frieden, T. R., Damon, I., Bell, B. P., Kenyon, T., & Nichol, S. (2014). Ebola 2014—new challenges, new global response and responsibility. New England Journal of Medicine, 371(13), 1177-1180.
-) Geisbert, T. W., & Feldmann, H. (2011). Recombinant vesicular stomatitis virus–based vaccines against Ebola and Marburg virus infections. Journal of Infectious Diseases, 204(suppl 3), S1075-S1081.
-) Geisbert, T. W., Hensley, L. E., Larsen, T., Young, H. A., Reed, D. S., Geisbert, J. B., ... & Davis, K. J. (2003). Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. The American journal of pathology, 163(6), 2347-2370.
-) Leroy, E. M., Kumulungui, B., Pourrut, X., Rouquet, P., Hassanin, A., Yaba, P., ... & Swanepoel, R. (2005). Fruit bats as reservoirs of Ebola virus. Nature, 438(7068), 575-576.
-) Macharia, J. (2014). How Nigeria Beat Ebola: Key Lessons for Kenya as told by CS James Macharia. Retrieved from: http://www.standardmedia.co.ke/health/article/2000139493/how-nigeria-beat-ebola-key-lessons-for-kenya-as-told-by-cs-james-macharia?pageNo=1
-) Martines, R.B., Ng, D.L., Greer, P.W., Rollin, P.E. & Zaki, S.R. (2014). Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. The Journal of Pathology, doi:10.1002/path.4456
-) Meltzer, M. I., Atkins, C. Y., Santibanez, S., Knust, B., Petersen, B. W., Ervin, E. D., ... & Washington, M. L. (2014). Estimating the future number of cases in the Ebola epidemic—Liberia and Sierra Leone, 2014–2015. MMWR Surveill Summ, 63(suppl 3), 1-14.
-) NIH/National Institute of Allergy and Infectious Diseases. (2014, September 8). Rapid and durable protection against Ebola virus with new vaccine regimens.ScienceDaily. Retrieved November 3, 2014 from www.sciencedaily.com/releases/2014/09/140908152930.htm
-) Qiu, X., Wong, G., Audget, J., Bello, A., Fernando, L., Alimonti, J.B., … & Kobinger, G.P. (2014). Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature, 514, 47-54.
-) Stanley, D. A., Honko, A. N., Asiedu, C., Trefry, J. C., Lau-Kilby, A. W., Johnson, J. C., ... & Sullivan, N. J. (2014). Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge. Nature medicine.
-) Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z. Y., & Nabel, G. J. (2000). Development of a preventive vaccine for Ebola virus infection in primates. Nature, 408(6812), 605-609.
-) Toner, E., Adalja, A., & Inglesby, T. (2014). A primer on ebola for clinicians. Disaster 	Medicine and Public Health Preparedness, 0(0). Retrieved from 	http://journals.cambridge.org/download.php?file=%2FDMP%2FS1935789314001	153a.pdf&code=34f64fea7fe14e214786ecfec8f757c2.
-) University of Texas Medical Branch at Galveston. (2014, August 29). Leading Ebola researcher says there's an effective treatment for Ebola. ScienceDaily. Retrieved November 3, 2014 from www.sciencedaily.com/releases/2014/08/140829135446.htm
-) Walker, D.H. & Paessler, S. (2013). Pathogenesis of the viral hemorrhagic fevers. Annual Review of Pathology Mechanisms of Disease, 8, 411-440.
-) Zeliadt, N. (2014, April 29). Ebola outbreak in West Africa lends urgency to recently-funded research. Retrieved from http://blogs.nature.com/spoonful/2014/04/ebola-outbreak-in-west-africa-lends-urgency-to-recently-funded-research.html.
@@ Line 456: / Line 400: @@
 World Health Organization (n.d.). 50 Facts: Global health situation and trends 1955-2025. Retrieved from: http://www.who.int/whr/1998/media_centre/50facts/en/

Differences

Search

Navigation

Print/export

Tools

QR Code